Clinical trial
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
NCT05240508 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
- Lead sponsor
- University of Vermont
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.